Results 101 to 110 of about 153,669 (262)
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
While internal marketing has been studied extensively in customer-facing roles and service industries, there is limited evidence on its effective application in technical, non-customer-facing contexts such as construction, creating a critical gap in the ...
Leonnard Ong +2 more
doaj +1 more source
A Comparison of Antimicrobials for the Textile Industry [PDF]
Robert A. Monticello, W. Curtis White
openaire +1 more source
A comparison between the database industries in the US and Japan
世界で最も歴史があり,産業規模も大きい米国のデータベース産業と比較することで,わが国データベース産業の現状と課題を明らかにした。データベース産業規模の重要な指標である売上高は,日米間で1995年以降拡大の傾向にあり,1997年には米国は日本の9.6倍となった。そこで,データベース産業を8種類の専門情報と消費者向けサービスの合計9種類の分野に分け,日米の産業規模の比較を行った。1999年のWeb/オンライン(データベース)サービス売上高は,米国が日本の14.7倍となっており,差がさらに拡大する傾向にある。米国と日本とのWeb/オンライン(データベース)サービスの分野別売上比率は,「株式取引関連」が12.0倍,「財務ニュース・リサーチ」が15.7倍,「市場情報」が127.7倍と大きく開いていたが,一方で「
openaire +2 more sources
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant +11 more
wiley +1 more source
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source
This study investigated a novel WST‐8‐based assay for evaluating d‐Amino acid oxidase (DAO) inhibitors. We confirmed its effectiveness using known inhibitors and found that uremic toxins possess relatively weak inhibitory activity compared to existing drugs.
Kahoko Miyake +4 more
wiley +1 more source

